Search Within

Lee M Krug

Formats
  1. Journal Article (94)
  2. Meeting Abstract (81)
  3. Book Section (8)
  4. Book Whole (1)
Groups
  1. Department of Medicine (128)
  2. Solid Tumor Oncology Division (126)
  3. Thoracic Oncology (122)
  4. Surgery (49)
  5. Department of Pathology and Laboratory Medicine (45)
  6. Nursing (37)

More Groups

People
  1. Mark Kris (86)
  2. Vincent Miller (43)
  3. Valerie Rusch (41)
  4. Christopher Azzoli (37)
  5. Maria Pietanza (37)
  6. Marjorie Zauderer (34)

More People

Years
  1. 2020 (1)
  2. 2018 (1)
  3. 2017 (2)
  4. 2016 (8)
  5. 2015 (14)
  6. 2014 (18)

More Years

Publications
  1. Journal of Thoracic Oncology (44)
  2. Journal of Clinical Oncology (43)
  3. Clinical Cancer Research (14)
  4. Lung Cancer (12)
  5. Journal of the National Comprehensive Cancer Network (10)
  6. Cancer (8)

More Publications

Publishers
  1. Elsevier Inc. (65)
  2. American Society of Clinical Oncology (43)
  3. American Association for Cancer Research (19)
  4. Elsevier Ireland Ltd. (11)
  5. Harborside Press (10)
  6. Springer (9)

More Publishers

Results (184)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase II study of arginine deprivation therapy with pegargiminase in patients with relapsed sensitive or refractory small-cell lung cancer
    Journal Article

    Hall, P. E.; Ready, N.; Johnston, A.; Bomalaski, J. S.; Venhaus, R. R.; Sheaff, M.; Krug, L.; Szlosarek, P. W.
    Clinical Lung Cancer (2020)

    Fulltext@MSK | Save
  • Randomized, double-blind, phase II study of temozolomide in combination with either veliparib or placebo in patients with relapsed-sensitive or refractory small-cell lung cancer
    Journal Article

    Pietanza, M. C.; Waqar, S. N.; Krug, L. M.; Dowlati, A.; Hann, C. L.; Chiappori, A.; Owonikoko, T. K.; Woo, K. M.; Cardnell, R. J.; Fujimoto, J.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • A randomized phase II trial of adjuvant galinpepimut-S, WT-1 analogue peptide vaccine, after multimodality therapy for patients with malignant pleural mesothelioma
    Journal Article

    Zauderer, M. G.; Tsao, A. S.; Dao, T.; Panageas, K.; Lai, W. V.; Rimner, A.; Rusch, V. W.; Adusumilli, P. S.; Ginsberg, M. S.; Gomez, D.; more...
    Clinical Cancer Research (2017)

    Fulltext@MSK | Save
  • Improved outcomes with modern lung-sparing trimodality therapy in patients with malignant pleural mesothelioma
    Journal Article

    Shaikh, F.; Zauderer, M. G.; von Reibnitz, D.; Wu, A. J.; Yorke, E. D.; Foster, A.; Shi, W.; Zhang, Z.; Adusumilli, P. S.; Rosenzweig, K. E.; more...
    Journal of Thoracic Oncology (2017)

    Fulltext@MSK | Save
  • The International Association for the Study of Lung Cancer Lung Cancer staging project: Proposals for the revision of the clinical and pathologic staging of small cell lung cancer in the forthcoming eighth edition of the TNM classification for lung cancer
    Journal Article

    Nicholson, A. G.; Chansky, K.; Crowley, J.; Beyruti, R.; Kubota, K.; Turrisi, A.; Eberhardt, W. E. E.; Van Meerbeeck, J.; Rami-Porta, R.; on behalf of the Staging and Prognostic Factors Committee, Advisory Boards, and Participating Institutions
    Journal of Thoracic Oncology (2016)

    Fulltext@MSK | Save
  • Randomized phase II study of adjuvant WT1 vaccine (SLS-001) for malignant pleural mesothelioma (MPM) after multimodality therapy
    Meeting Abstract

    Zauderer, M. G.; Dao, T.; Rusch, V. W.; Ginsberg, M. S.; Tsao, A. S.; Panageas, K.; Stergiou, A. M.; Scheinberg, D. A.; Krug, L. M.
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • A multi-center, randomized, double-blind phase II study comparing temozolomide (TMZ) plus either veliparib (ABT-888), a PARP inhibitor, or placebo as 2nd or 3rd-line therapy for patients (Pts) with relapsed small cell lung cancers (SCLCs)
    Meeting Abstract

    Pietanza, M. C.; Krug, L. M.; Waqar, S. N.; Dowlati, A.; Hann, C. L.; Chiappori, A.; Owonikoko, T. K.; Woo, K.; Bensman, Y.; Hurtado, B.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Phase II study of hemithoracic intensity-modulated pleural radiation therapy (IMPRINT) as part of lung-sparing multimodality therapy in patients with malignant pleural mesothelioma
    Journal Article

    Rimner, A.; Zauderer, M. G.; Gomez, D. R.; Adusumilli, P. S.; Parhar, P. K.; Wu, A. J.; Woo, K. M.; Shen, R.; Ginsberg, M. S.; Yorke, E. D.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • A phase I trial of the Hedgehog inhibitor, sonidegib (LDE225), in combination with etoposide and cisplatin for the initial treatment of extensive stage small cell lung cancer
    Journal Article

    Pietanza, M. C.; Litvak, A. M.; Varghese, A. M.; Krug, L. M.; Fleisher, M.; Teitcher, J. B.; Holodny, A. I.; Sima, C. S.; Woo, K. M.; Ng, K. K.; more...
    Lung Cancer (2016)

    Fulltext@MSK | Save
  • Phase I study of apitolisib (GDC-0980), dual phosphatidylinositol-3-kinase and mammalian target of rapamycin kinase inhibitor, in patients with advanced solid tumors
    Journal Article

    Dolly, S. O.; Wagner, A. J.; Bendell, J. C.; Kindler, H. L.; Krug, L. M.; Seiwert, T. Y.; Zauderer, M. G.; Lolkema, M. P.; Apt, D.; Yeh, R. F.; more...
    Clinical Cancer Research (2016)

    Fulltext@MSK | Save